Julius Knowles, Director at Keros Therapeutics, Inc. (KROS), sold 91,781 shares at $56.10 ($5.3M) on 2022-01-04, disclosed to the SEC on 2022-01-05.
Open-market sale of $5.3M KROS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.82 | 2,406 | $137K | 2.6% |
| 2 | $56.82 | 2,406 | $137K | 2.6% |
| 3 | $56.82 | 3,678 | $209K | 3.9% |
| 4 | $56.82 | 3,678 | $209K | 3.9% |
| 5 | $57.83 | 5,094 | $295K | 5.5% |
| 6 | $57.83 | 3,318 |
| $192K |
| 3.6% |
| 7 | $57.83 | 3,318 | $192K | 3.6% |
| 8 | $57.83 | 5,094 | $295K | 5.5% |
| 9 | $58.96 | 3,412 | $201K | 3.8% |
| 10 | $58.96 | 5,236 | $309K | 5.8% |
| 11 | $58.96 | 5,236 | $309K | 5.8% |
| 12 | $58.96 | 3,412 | $201K | 3.8% |
| 13 | $59.40 | 249 | $15K | 0.3% |
| 14 | $59.40 | 162 | $10K | 0.2% |
| 15 | $54.95 | 524 | $29K | 0.5% |
| 16 | $54.95 | 794 | $44K | 0.8% |
| 17 | $56.10 | 1,383 | $78K | 1.5% |
| 18 | $56.10 | 2,124 | $119K | 2.2% |
| 19 | $56.10 | 2,124 | $119K | 2.2% |
| 20 | $56.10 | 1,383 | $78K | 1.5% |
| 21 | $56.95 | 1,113 | $63K | 1.2% |
| 22 | $56.95 | 1,113 | $63K | 1.2% |
| 23 | $56.95 | 1,707 | $97K | 1.8% |
| 24 | $56.95 | 1,707 | $97K | 1.8% |
| 25 | $57.99 | 2,704 | $157K | 3.0% |
| 26 | $57.99 | 2,704 | $157K | 3.0% |
| 27 | $57.99 | 4,151 | $241K | 4.5% |
| 28 | $57.99 | 4,151 | $241K | 4.5% |
| 29 | $58.86 | 3,367 | $198K | 3.7% |
| 30 | $58.86 | 2,195 | $129K | 2.4% |
| 31 | $58.86 | 2,195 | $129K | 2.4% |
| 32 | $58.86 | 3,367 | $198K | 3.7% |
| 33 | $57.23 | 271 | $16K | 0.3% |
| 34 | $57.23 | 419 | $24K | 0.5% |
| 35 | $58.20 | 1,356 | $79K | 1.5% |
| 36 | $58.20 | 886 | $52K | 1.0% |
| 37 | $58.20 | 1,356 | $79K | 1.5% |
| 38 | $58.20 | 886 | $52K | 1.0% |
| 39 | $59.00 | 667 | $39K | 0.7% |
| 40 | $59.00 | 435 | $26K | 0.5% |
| Total | $57.86 avg | 91,781 | $5.3M | 100% |
| Filing → |
| KROS | SELL | 2021-12-03 | $5.1M | — | Filing → |
| KROS | SELL | 2021-11-03 | $3.9M | — | Filing → |
| KROS | SELL | 2021-10-21 | $598K | — | Filing → |